Navigation Links
University of East Anglia makes cancer breakthrough
Date:10/14/2010

Scientists at the University of East Anglia have made an important breakthrough in the way anti-cancer drugs are tested.

A tumour cannot grow to a large size or spread until it has developed its own blood supply and leading research has looked for a way of halting capillary formation to stop tumours taking hold.

But new findings published today in the Journal of Cell Science have shown that scientists testing such treatments may not have been studying exactly what they thought they were.

The research proves that cells are able to switch their genetic profile turning off genes expressed by blood vessel cells and turning on genes specific to lymphatic cells.

This "switch" was previously thought to be impossible and means that scientists may have been researching lymphatic cells, rather than blood vessel cells. It is hoped the discovery will propel the race to find revolutionary new treatments.

Lead author Dr Lin Cooley, said: "It has always been thought that cells could not change from blood to lymphatic vascular cells.

"Other researchers have been doing experiments thinking they were looking at blood vessel cells, when in fact they were looking at lymphatic vascular cells. This breakthrough is important because they have not been studying what they think they have been studying.

"It is a big discovery and will be very important in testing potential anti-cancer drugs."

Researchers used human vein cells in experiments where they form capillaries - the smallest of the body's blood vessels - when cultured in various environments similar to the body.

The human vascular system is made up of two separate circulatory networks the blood and lymphatic vasculature. Blood vessels and lymphatic vessels are structurally similar, but have very different roles, and are made up of two distinct cell types.

Dr Cooley said: "We have discovered that when vein cells form tube structures, they appear to "switch" their genetic profile, turning off genes expressed by blood vessel cells, and turning on genes specific to lymphatic vessels.

"This change can be reversed, and is dependent on the particular environment they are cultured in.

"We have also shown that their identity changes in response to the cell's environment rather than only being specified by signals during early embryonic development".


'/>"/>

Contact: Lisa Horton
l.horton@uea.ac.uk
44-016-035-92226
University of East Anglia
Source:Eurekalert  

Related medicine news :

1. University of Miami receives grant to increase the number of family nurse practitioners
2. University of Colorado gets federal award for Cord Blood Bank
3. UC San Diego partners with Mozambique University to deliver quality health care
4. Better cholesterol drugs may follow Saint Louis University researchers breakthrough
5. U-M Medical School creates joint institute with Peking University
6. University Hospitals Case Medical Centers neuroscience intensive care unit earns Beacon Award
7. Researchers at the University of Granada associate trigger points with shoulder injury
8. The University of Warsaw obtains 3-year site license to Science to provide site-wide access to research institutions in Poland
9. McGill to host inter-university Family Medicine Student Symposium
10. University Hospitals Case Medical Center implements AutoLITT system for treatment of brain tumors
11. Queens University researchers locate impulse control center in brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
University of East Anglia makes cancer breakthrough
(Date:5/24/2017)... ... May 24, 2017 , ... In ... choosing the most appropriate instruments for research and understanding the basic principles that ... webinar will focus on innovations in stereo microscopy for brightfield and fluorescence typically ...
(Date:5/24/2017)... ... May 24, 2017 , ... Altec Products, Inc., a ... 2017 – a one-day technology conference in San Diego, CA. , At nVerge ... users to fully utilize and enhance their Sage ERP solutions by providing improved visibility ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... implants in Bayside, NY, who have now spent 10 years as clinical instructors ... York University (NYU) College of Dentistry. Through the program, private practitioners receive cutting-edge ...
(Date:5/24/2017)... , ... May 24, 2017 , ... Patients who want ... OH, can now meet with Dr. Joseph Bedich for a consultation, with or without ... improving their oral health and functionality. , Dr. Bedich offers a variety ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Myers Jackson ... his has the ability to sell luxury homes anywhere on the planet. The luxury ... county side from Hattiesburg to Houston city-scapes. A quick search of “11 Spyglass Hill ...
Breaking Medicine News(10 mins):
(Date:5/3/2017)... 2017  Kalorama Information notes that transplant diagnostics ... year and this is projected to continue to ... (HSCT) or bone marrow transplants require histocompatibility between ... for this task. This according to a new ... The various PCR-based methodologies, Sanger sequencing and NGS ...
(Date:5/3/2017)... 2017  West Pharmaceutical Services, Inc. (NYSE: WST), ... drug administration, announced today that Fran DeGrazio ... and Diane Paskiet , Director, Scientific Affairs, ... on West,s expertise in the areas of safety ... providing commentary on updated industry guidance. ...
(Date:5/2/2017)... SYDNEY , May 2, 2017  George Clinical, ... Asia-Pacific region, and Vector Oncology, a ... research and data analytics, formally announced today that George ... immediately, the transaction has the dual purpose of ... scientifically led oncology trial delivery solutions throughout the ...
Breaking Medicine Technology: